Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robbert J Slebos

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Seminars in Oncology|June 12, 2008
Update on molecular diagnostic tests in head and neck cancerKevin T Palka, Robbert J Slebos, Christine H Chung
International Journal of Radiation Oncology, Biology, Physics|October 18, 2007
Gene expression profiles as markers of aggressive disease-EGFR as a factorChristine H Chung, Joel Parker, Shawn Levy, et al.
Journal of Proteome Research|February 6, 2010
TagRecon: high-throughput mutation identification through sequence taggingSurendra Dasari, Matthew C Chambers, Robbert J Slebos, et al.
Journal of Proteome Research|June 20, 2008
Global impact of oncogenic Src on a phosphotyrosine proteomeWeifeng Luo, Robbert J Slebos, Salisha Hill, et al.
Cancer Research|August 17, 2006
Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinomaChristine H Chung, Joel S Parker, Kim Ely, et al.
The New England Journal of Medicine|March 14, 2008
Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactoseChristine H Chung, Beloo Mirakhur, Emily Chan, et al.
Plos One|September 22, 2010
Regulation of heparin-binding EGF-like growth factor by miR-212 and acquired cetuximab-resistance in head and neck squamous cell carcinomaHiromitsu Hatakeyama, Haixia Cheng, Pamela Wirth, et al.
JAMA Otolaryngology-- Head & Neck Surgery|March 29, 2019
Human Papillomavirus Genotype Detection in Oral Gargle Samples Among Men With Newly Diagnosed Oropharyngeal Squamous Cell CarcinomaLaura Martin-Gomez, Anna R Giuliano, William J Fulp, et al.
Lancet (London, England)|September 15, 2022
Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trialSungjune Kim, Evan Wuthrick, Dukagjin Blakaj, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Seminars in Oncology|June 12, 2008
Update on molecular diagnostic tests in head and neck cancerKevin T Palka, Robbert J Slebos, Christine H Chung
International Journal of Radiation Oncology, Biology, Physics|October 18, 2007
Gene expression profiles as markers of aggressive disease-EGFR as a factorChristine H Chung, Joel Parker, Shawn Levy, et al.
Journal of Proteome Research|February 6, 2010
TagRecon: high-throughput mutation identification through sequence taggingSurendra Dasari, Matthew C Chambers, Robbert J Slebos, et al.
Journal of Proteome Research|June 20, 2008
Global impact of oncogenic Src on a phosphotyrosine proteomeWeifeng Luo, Robbert J Slebos, Salisha Hill, et al.
Cancer Research|August 17, 2006
Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinomaChristine H Chung, Joel S Parker, Kim Ely, et al.
The New England Journal of Medicine|March 14, 2008
Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactoseChristine H Chung, Beloo Mirakhur, Emily Chan, et al.
Plos One|September 22, 2010
Regulation of heparin-binding EGF-like growth factor by miR-212 and acquired cetuximab-resistance in head and neck squamous cell carcinomaHiromitsu Hatakeyama, Haixia Cheng, Pamela Wirth, et al.
JAMA Otolaryngology-- Head & Neck Surgery|March 29, 2019
Human Papillomavirus Genotype Detection in Oral Gargle Samples Among Men With Newly Diagnosed Oropharyngeal Squamous Cell CarcinomaLaura Martin-Gomez, Anna R Giuliano, William J Fulp, et al.
Lancet (London, England)|September 15, 2022
Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trialSungjune Kim, Evan Wuthrick, Dukagjin Blakaj, et al.
Pageof 1